Dashboard
Manage Tickers

VNDAVanda Pharmaceuticals Inc.

Nasdaq vandapharma.com


$ 6.25 $ -0.26 (-4 %)    

Friday, 14-Jun-2024 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 6.24
$ 6.44
$ 0.00 x 0
$ 0.00 x 0
$ 6.23 - $ 6.66
$ 3.30 - $ 6.76
1,134,894
na
360.43M
$ 0.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-08-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 07-28-2023 06-30-2023 10-Q
5 05-03-2023 03-31-2023 10-Q
6 02-09-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 07-29-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 02-11-2021 12-31-2020 10-K
15 10-29-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-26-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-03-2019 03-31-2019 10-Q
22 02-19-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-15-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-03-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 02-17-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 07-28-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 02-12-2016 12-31-2015 10-K
35 11-04-2015 09-30-2015 10-Q
36 07-31-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 03-13-2015 12-31-2014 10-K
39 10-27-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

tesla-nvidia-john-wiley--sons-and-other-big-stocks-moving-higher-on-thursday
Tesla, Nvidia, John Wiley & Sons And Other...
06/13/2024 14:17:19

vanda-pharmaceuticals-receives-revised-unsolicited-acquisition-proposal-from-future-pak-for-850-900-per-share-in-cash-plus-contingent-value-rights-no-shareholder-action-required-at-this-time
Vanda Pharmaceuticals Receives Revised Uns...
06/13/2024 14:03:49

future-pak-increases-cash-portion-of-its-offer-for-vanda-pharmaceuticals-by-075-125-to-850-900-per-share
Future Pak Increases Cash Portion Of Its O...
06/13/2024 12:18:38

https://www.businesswire.com/news/home/20240613906873/en/https://www.businesswire.com/news/home/20240613906873/en/

sp-500-edges-lower-j-m-smucker-shares-surge-following-earnings-beat
S&P 500 Edges Lower; J. M. Smucker Shares ...
06/06/2024 18:45:57

why-g-iii-apparel-shares-are-trading-lower-by-13-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why G-III Apparel Shares Are Trading Lower...
06/06/2024 17:39:18

crude-oil-jumps-2-lululemon-posts-upbeat-earnings
Crude Oil Jumps 2%; Lululemon Posts Upbeat...
06/06/2024 16:22:51

vanda-pharmaceuticals-receives-another-takeover-proposal-considers-466m-deal
Vanda Pharmaceuticals Receives Another Tak...
06/06/2024 16:13:16

Cycle Pharmaceuticals wants to acquire Vanda Pharmaceuticals for $8 per share, or $466 million. Cycle focuses on rare neurologi...

vanda-pharmaceuticals-confirms-unsolicited-non-binding-acquisition-proposal-from-cycle-group-holdings-at-800-per-share-in-cash
Vanda Pharmaceuticals Confirms Unsolicited...
06/06/2024 13:25:08

correction-vanda-pharmaceuticals-shares-are-trading-higher
CORRECTION: Vanda Pharmaceuticals shares a...
06/06/2024 12:15:15

cycle-pharmaceuticals-made-a-proposal-to-vanda-pharmaceuticals-to-acquire-100-of-shares-for-8share-total-cash-consideration-466m
Cycle Pharmaceuticals Made A Proposal To V...
06/06/2024 12:08:30

vanda-pharmaceuticals-gains-ownership-of-the-us-nda-and-ind-applications-for-ponvory-from-a-johnson--johnson-company-which-now-fully-allows-vanda-to-commercialize-ponvory-in-the-us
Vanda Pharmaceuticals Gains Ownership Of T...
05/30/2024 21:07:16

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced that ownership of the U.S. New Drug Application and Investigat...

vanda-pharmaceuticals-rejects-revised-unsolicited-acquisition-proposal-from-future-pak-concluding-it-undervalues-the-company-board-unanimously-decides-proposal-is-not-in-the-best-interests-of-shareholders
Vanda Pharmaceuticals Rejects Revised Unso...
05/24/2024 20:48:10

vanda-pharmaceuticals-announces-positive-results-from-second-phase-iii-study-of-tradipitant-confirming-efficacy-in-preventing-motion-sickness-related-vomiting
Vanda Pharmaceuticals Announces Positive R...
05/15/2024 12:46:39

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced the results from its second Phase III study of tradipitant in ...

exact-sciences-reports-q1-loss-joins-beyond-meat-duolingo-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Exact Sciences Reports Q1 Loss, Joins Beyo...
05/09/2024 09:49:11

vanda-pharma-q1-2024-gaap-eps-007-misses-005-estimate-sales-47462m-miss-48500m-estimate
Vanda Pharma Q1 2024 GAAP EPS $(0.07) Miss...
05/08/2024 20:27:58

Vanda Pharma (NASDAQ:VNDA) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $0.05 ...

vanda-pharmaceuticals-confirms-receipt-of-revised-unsolicited-takeover-proposal-from-future-pak-says-co-does-not-intend-to-comment-further-on-the-revised-unsolicited-proposal-before-the-board-has-completed-its-review
Vanda Pharmaceuticals Confirms Receipt Of ...
05/07/2024 15:18:16

No Shareholder Action Required at This TimeWASHINGTON, May 7, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" ...

future-pak-increases-bid-for-vanda-pharmaceuticals-to-include-cvrs-in-addition-to-725-775-per-share-in-cash-offer-represents-1162-1212-per-share
Future Pak Increases Bid For Vanda Pharmac...
05/07/2024 13:03:23

vanda-pharmaceuticals-shareholder-sharecap-says-company-board-must-explore-strategic-alternatives
Vanda Pharmaceuticals Shareholder ShareCap...
04/25/2024 12:08:59

ShareCap calls on the Board to initiate a strategic alternatives process that, among the alternatives, reconsiders Future Pak&#...

us-supreme-court-declines-to-hear-vanda-pharmaceuticals-case-regarding-invalidation-of-patents-for-its-sleep-disorder-drug-hetlioz
US Supreme Court Declines To Hear Vanda Ph...
04/22/2024 18:37:55

"Supreme Court denies review of Vanda Pharmaceuticals' patent revival attempt for Hetlioz sleep-disorder medication. Le...

Core News & Articles
'The U.S Supreme Court Has Reportedly Decl...
04/22/2024 16:05:31

https://finance.yahoo.com/news/1-u-supreme-court-rejects-153720025.htmlThe U.S. Supreme Court on Monday declined to hear a bid ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)